| Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studies E Faught, H Besson, W D’Souza, P Klein, M Reuber, F Rosenow, ... Epilepsy & Behavior 158, 109922, 2024 | | 2024 |
| 3130 Evaluation of the delivery of specialist first seizure care in Australia J Jiang, E Foster, D Vaughan, W D'Souza, P Carney BMJ Neurology Open 6 (Suppl 1), 2024 | | 2024 |
| User experience of a seizure risk forecasting app: A mixed methods investigation RE Stirling, ES Nurse, D Payne, J Naim-Feil, H Coleman, DR Freestone, ... Epilepsy & Behavior 157, 109876, 2024 | 1 | 2024 |
| Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study N Delanty, R Mohanraj, R Shankar, T Wehner, LJ Stephen, W D’Souza, ... Epilepsy Research 202, 107339, 2024 | 2 | 2024 |
| 12-month Effectiveness and Tolerability of Brivaracetam in Patients with Epilepsy and Cognitive or Psychiatric Comorbidities: Subgroup Data from the International EXPERIENCE … V Villanueva, W D’Souza, E Faught, P Klein, M Reuber, F Rosenow, ... Neurology 102 (17_supplement_1), 3062, 2024 | | 2024 |
| Applying the ILAE diagnostic criteria for Lennox‐Gastaut syndrome in the real‐world setting: A multicenter retrospective cohort study R Nightscales, Z Chen, S Barnard, C Auvrez, G Tao, S Sivathamboo, ... Epilepsia Open 9 (2), 602-612, 2024 | 2 | 2024 |
| Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the … JP Szaflarski, H Besson, W D’Souza, E Faught, P Klein, M Reuber, ... Journal of Neurology, 1-17, 2024 | 2 | 2024 |
| Perampanel for treatment of focal and generalized epilepsy in everyday clinical practice: Evidence from permit extension E Trinka, R Wechsler, W D’souza, T Wu, I Najm, L Ngo, R Mcmurray, ... Journal of the Neurological Sciences 455, 2023 | | 2023 |
| Using seizure cycle forecasts to identify optimal monitoring timeframes and improve the diagnostic yield of vEEG J Naim-Feil, RE Stirling, D Eden, DE Payne, M Maturana, DB Grayden, ... EPILEPSIA 64, 189-190, 2023 | | 2023 |
| 12-month effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by etiology at baseline in the real-world: subgroup data from the international … A Strzelczyk, W D'Souza, E Faught, P Klein, M Reuber, F Rosenow, ... EPILEPSIA 64, 18-19, 2023 | | 2023 |
| 12-Month effectiveness and tolerability of brivaracetam in patients with epilepsy switching from levetiracetam vs other antiseizure medications in the real-world: subgroup data … BJ Steinhoff, W D'Souza, E Faught, P Klein, M Reuber, F Rosenow, ... EPILEPSIA 64, 274-274, 2023 | | 2023 |
| International case control study of Sudden Unexpected Death in Epilepsy (SUDEP) P Bergin, S Sasikumar, M Pail, SL Fong, I Rodriguez, F Rivas, SK Guler, ... EPILEPSIA 64, 183-184, 2023 | | 2023 |
| Multi-day seizure cycles are similar in paediatric and adult epilepsy H Kamitakahara, P Karoly, D Eden, E Nurse, R Stirling, W D'Souza, ... EPILEPSIA 64, 156-156, 2023 | | 2023 |
| Real-world experience of treating patients aged< 12 years with perampanel A Garcia-Ron, M Chez, S Auvin, T Wu, W D'Souza, LY Ngo, O Samad, ... EPILEPSIA 64, 286-287, 2023 | | 2023 |
| Prospective validation of a mobile and wearable app to forecast seizure risk R Stirling, D Payne, W Xiong, E Nurse, W Campbell, D Freestone, M Cook, ... EPILEPSIA 64, 54-55, 2023 | | 2023 |
| Circadian distribution of epileptiform discharges in epilepsy: Candidate mechanisms of variability I Marinelli, JJ Walker, U Seneviratne, W D’Souza, MJ Cook, C Anderson, ... PLoS Computational Biology 19 (10), e1010508, 2023 | 2 | 2023 |
| RHYTHMS OF THE BRAIN: MULTIDAY SEIZURE CYCLES AND SEIZURE-RISK FORECASTS TO IMPROVE THE DIAGNOSTIC YIELD OF AMBULATORY VIDEO-ELECTROENCEPHALOGRAPHY J Naim-Feil, R Stirling, N Winterling, D Eden, D Payne, M Maturana, ... IBRO Neuroscience Reports 15, S742, 2023 | | 2023 |
| Neuropsychological function in psychosis of epilepsy J Allebone, RA Kanaan, G Rayner, J Maller, TJ O’Brien, SA Mullen, ... Epilepsy Research 196, 107222, 2023 | 1 | 2023 |
| Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: the PERMIT extension study J Wheless, RT Wechsler, P Penovich, E Segal, M Chez, A Coppola, ... Epilepsy & Behavior 147, 109369, 2023 | 5 | 2023 |
| Effectiveness and tolerability of 12-month brivaracetam in the real world: EXPERIENCE, an international pooled analysis of individual patient records V Villanueva, C Laloyaux, W D’Souza, E Faught, P Klein, M Reuber, ... CNS drugs 37 (9), 819-835, 2023 | 9 | 2023 |
Mark CookUniversity of Melbourne在 unimelb.edu.au 的电子邮件经过验证
